Artelo Biosciences announces $9.475 million private placement plan to launch Solana's financial strategy

PANews September 9th news, Nasdaq listed company Artelo Biosciences (NASDAQ: ARTL) announced the launch of the underwriting public offering of common stock and/or advance warrants, with R.F. Lafferty & Co., Inc. as the sole bookkeeper. In addition, Artelo announced a private fundraising program worth $9.475 million, which will launch a financial strategy based on the Solana blockchain, becoming one of the first companies to adopt Solana cryptocurrency as its core reserve asset.